13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$414.45B
+6.6% on the quarter before
Positions
434
27 new · 30 sold out
Top 10
27.1%
of the value
Est. gain
+$27.65B
on stocks held all quarter
Est. return
+7.7%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Johnson & Johnson~$1.78BAdded · 0.7% → 1.1%+10,724,110 shares
- Salesforce~$1.38BAdded · 0.0% → 0.4%+6,548,396 shares
- Wells Fargo Co New~$1.08BAdded · 0.4% → 0.6%+25,268,032 shares
- Carrier Global~$1.07BAdded · 0.7% → 0.9%+21,529,209 shares
- Dollar Gen Corp New~$1.01BAdded · 0.5% → 0.6%+5,926,555 shares
- Pnc Finl Svcs Group Inc~$934.3MAdded · 0.0% → 0.3%+7,417,830 shares
- Visa Inc.~$873.3MAdded · 1.0% → 1.2%+3,678,089 shares
- Delta Air Lines Inc Del~$747.8MAdded · 0.0% → 0.2%+15,729,876 shares
- Csx Corp~$686.2MAdded · 0.1% → 0.3%+20,126,839 shares
- Danaher Corporation~$607.8MAdded · 0.7% → 0.8%+2,532,666 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$4.06BCut · 4.6% → 4.8%−4,675,754 shares
- Seagen Inc~$1.62BCut · 0.8% → 0.3%−8,429,389 shares
- Albemarle Corp~$1.60BCut · 0.5% → 0.1%−7,182,140 shares
- Norfolk Southn Corp~$1.21BCut · 0.3% → 0.0%−5,339,939 shares
- Amazon~$1.15BCut · 1.2% → 1.1%−8,835,986 shares
- Fidelity Natl Information Sv~$1.02BCut · 0.4% → 0.1%−18,616,841 shares
- Pfizer Inc~$1.00BCut · 0.6% → 0.3%−27,358,256 shares
- Comcast Corp New~$640.3MCut · 1.8% → 1.7%−15,409,401 shares
- Unitedhealth Group Inc~$616.2MCut · 1.8% → 1.6%−1,282,285 shares
- Abb Ltd~$604.7MSold out · 0.2% → 0.0%−17,736,453 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.5% · price +18.1% | 6.9% | $28.51B | +$4.37B | ||||||||
| BroadcomCOM · shares −17% · price +35.2% | 4.8% | $19.87B | +$5.18B | ||||||||
| Philip Morris Intl IncCOM · shares +1.0% · price +0.4% | 2.5% | $10.38B | +$39.5M | ||||||||
| MetaCL A · shares −5.4% · price +35.4% | 2.5% | $10.28B | +$2.69B | ||||||||
| AlphabetCAP STK CL C · shares −5.7% · price +16.3% | 2.4% | $9.77B | +$1.37B | ||||||||
| MastercardCL A · shares +6.8% · price +8.2% | 1.8% | $7.62B | +$542.0M | ||||||||
| Comcast Corp NewCL A · shares −8.2% · price +9.6% | 1.7% | $7.15B | +$626.9M | ||||||||
| Unitedhealth Group IncCOM · shares −8.7% · price +1.7% | 1.6% | $6.50B | +$108.5M | ||||||||
| Abbott LabsCOM · shares +4.9% · price +7.7% | 1.6% | $6.45B | +$438.2M | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.1% · price +11.6% | 1.4% | $5.97B | +$620.7M | ||||||||
| General Electric CoCOM NEW · shares +0.3% · price +14.9% | 1.4% | $5.96B | +$770.8M | ||||||||
| Transdigm Group IncCOM · shares +0.2% · price +21.3% | 1.4% | $5.88B | +$1.03B | ||||||||
| Abbvie IncCOM · shares +0.9% · price −15.5% | 1.4% | $5.81B | −$1.05B | ||||||||
| Northrop Grumman CorpCOM · shares +1.3% · price −1.3% | 1.3% | $5.55B | −$71.7M | ||||||||
| AppleCOM · shares +7.4% · price +17.6% | 1.3% | $5.27B | +$734.7M | ||||||||
| NetflixCOM · shares −10% · price +27.5% | 1.2% | $4.92B | +$1.06B | ||||||||
| Visa Inc.COM CL A · shares +22% · price +5.3% | 1.2% | $4.86B | +$201.8M | ||||||||
| Johnson & JohnsonCOM · shares +63% · price +6.8% | 1.1% | $4.61B | +$180.0M | ||||||||
| AmazonCOM · shares −20% · price +26.2% | 1.1% | $4.53B | +$940.4M | ||||||||
| Raytheon Technologies CorpCOM · shares −1.3% · price +0.0% | 1.1% | $4.45B | +$1.5M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +13% · price −7.7% | 1.1% | $4.43B | −$328.7M | ||||||||
| Linde PlcSHS · shares −1.5% · price +7.2% | 1.0% | $4.27B | +$287.7M | ||||||||
| SempraCOM · shares +12% · price −3.7% | 0.96% | $4.00B | −$136.9M | ||||||||
| Carrier GlobalCOM · shares +38% · price +8.7% | 0.94% | $3.88B | +$224.3M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares +0.06% · price +12.9% | 0.93% | $3.84B | +$439.2M | ||||||||
| Total · 434 positions | 100% | $414.45B | +$27.65B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 407 stocks held throughout, up $27.65B (+7.7%).
- Broadcom+$5.18B+35%
- Microsoft+$4.37B+18%
- Meta+$2.69B+35%
- Alphabet+$1.37B+16%
- Royal Caribbean Group+$1.10B+59%
- Crown Castle Inc−$255.9M−15%
- General Mls Inc−$288.1M−10%
- Bristol-Myers Squibb Co−$328.7M−8%
- Dollar Gen Corp New−$372.5M−19%
- Abbvie Inc−$1.05B−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |